Brüggemann, M, Raff, T, Flohr, T, et al., 2006. Clinical significance of minimal residual disease in adult patients with standard-risk acute lymphoblastic leukemia. Blood 107: 1116–23.CrossRefGoogle ScholarPubMed

Eapen, M, Rubenstein, P, Zhang, MJ, et al., 2006. Comparable survival after HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 24: 145–51.CrossRefGoogle ScholarPubMed

Fielding, AK, Richards, SM, Chopra, R, et al., 2007. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood 109: 944–50.CrossRefGoogle ScholarPubMed

Gleixnet, B, Gökbuget, N, Bartram, CR, et al., 2002. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reactions. Blood 99: 1536–43.Google Scholar

Gökbuget, N, Hoelzer, D. 2006. Treatment of acute lymphoblastic leukemia. Hematology 2006 (Educational Program of the American Society for Hematology) 133–41.CrossRefGoogle Scholar

Hahn, T, Wall, D, Camitta, B, et al., 2006. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marr Transpl 12: 1–30.CrossRefGoogle Scholar

Hahn, T, Wall, D, Camitta, B. 2006. ASBMT position statement. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in children. Biol Blood Marr Transpl 12: 370–71.Google Scholar

Hunault, M, Harousseau, Jl, Delain, M, et al., 2004. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood 104: 3028–37.CrossRefGoogle ScholarPubMed

Lazarus, HM, Luger, S. 2007. Which patients with adult acute lymphoblastic leukemia should undergo a hematopoietic stem cell transplant? Case-based discussion. ASH Educational Program 2007: 444–52.

Marks, DI, Aversa, F, Lazarus, HM (2006) Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options. Bone Marr Transpl 38: 467–75.CrossRef

Mato, AR, Luger, SM. 2006. Autologous stem cell transplant in ALL: who should we be transplanting in first remission?Bone Marr Transpl 37: 989–95.CrossRefGoogle ScholarPubMed

Munker, R, Hiller, E, Glass, J, Paquette, R (Eds). 2007. Modern Hematology. Totowa NJ: Humana Press.CrossRef

Oh, H, Gale, RP, Zhang, MJ, et al., 1998. Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission. Bone Marr Transpl 22: 253–57.CrossRefGoogle ScholarPubMed

Pui, CH, Evans, WE. 2006. Treatment of acute lymphoblastic leukemiaN Engl J Med 354: 166–78.CrossRefGoogle ScholarPubMed

Ramanujachar, R, Richards, S, Hann, I, et al., 2007. Adolescents with acute lymphoblastic leukemia: outcome on UK National Paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer 48: 254–61.CrossRefGoogle ScholarPubMed

Saarinen-Pihkala, UM, Gustafsson, G, Riugdén, O, et al., 2001. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol 19: 3406–14.CrossRefGoogle ScholarPubMed